Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Tax Provisions: 2013-2024

Historic Tax Provisions for CytomX Therapeutics (CTMX) over the last 10 years, with Dec 2024 value amounting to $224,000.

  • CytomX Therapeutics' Tax Provisions fell 4.92% to $58,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $245,000, marking a year-over-year decrease of 80.08%. This contributed to the annual value of $224,000 for FY2024, which is 94.24% down from last year.
  • According to the latest figures from FY2024, CytomX Therapeutics' Tax Provisions is $224,000, which was down 94.24% from $3.9 million recorded in FY2023.
  • Over the past 5 years, CytomX Therapeutics' Tax Provisions peaked at $3.9 million during FY2023, and registered a low of -$13.9 million during FY2020.
  • Its 2-year average for Tax Provisions is $2.1 million, with a median of $2.1 million in 2023.
  • Data for CytomX Therapeutics' Tax Provisions shows a maximum YoY tumbled of 3,157.85% (in 2020) over the last 5 years.
  • Over the past 3 years, CytomX Therapeutics' Tax Provisions (Yearly) stood at -$13.9 million in 2020, then reached $3.9 million in 2023, then crashed by 94.24% to $224,000 in 2024.